Basilea Pharmaceutica AG is a biopharmaceutical company, which engages in discovery, development, and commercialization of innovative pharmaceutical products. It operates through the following geographical segments: Switzerland, China, United Kingdom, and Japan. It's discover and develop antibiotics, antifungal, and oncology drugs. Its products include Cresemba Isavuconazole, Zevtera/Mabelio Ceftobiprole, Toctino, and Microbiology Test. The company was founded on October 17, 2000 and is headquartered in Basel, Switzerland.